Not one disease but a cluster of five measurements that tend to travel together, and that together predict cardiovascular disease and type 2 diabetes better than any of them alone. Roughly one in three US adults meets the criteria2. It is also the diagnosis on this site most responsive to what you eat.
Last updated:
A diagnosis you receive when any three of five specific measurements fall outside their thresholds at the same time. No single one of them is metabolic syndrome; the clustering is the point.
The five come from a joint statement agreed in 2009 by the International Diabetes Federation, the American Heart Association and several other bodies, which ended a long period in which different organisations used different cut-offs and produced different prevalence figures from the same population1.
What links them is not coincidence. Visceral fat, the fat packed around the liver and pancreas rather than under the skin, releases free fatty acids and inflammatory signals into the portal circulation. That drives insulin resistance, and insulin resistance in turn raises triglycerides, lowers HDL, pushes blood pressure up and lifts fasting glucose. One upstream process, five downstream measurements.
Three mildly abnormal readings together carry more risk than one markedly abnormal reading alone. The syndrome exists because the combination predicts outcomes the individual numbers do not.
Waist circumference is one of the five criteria and body weight is not. Where fat sits carries the metabolic risk, which is why a tape measure earns its place beside the scale.
Because the criteria are thresholds rather than damage, crossing back below them is possible. In one trial a Mediterranean-style diet returned more than half of participants to below the diagnostic threshold within two years4.
Metabolic syndrome has almost no symptoms. It is found on a blood test and with a tape measure, which is why it is so often missed until something else brings someone to a clinic.
| Criterion | Threshold | What it reflects |
|---|---|---|
| Waist circumference | Population and country specific; in the United States commonly 102 cm or more in men and 88 cm or more in women, with lower cut-offs used for several Asian populations | Visceral fat, the driver most upstream of the other four |
| Triglycerides | 150 mg/dL or above, or already treated for it | How much fat the liver is exporting, which rises with insulin resistance |
| HDL cholesterol | Below 40 mg/dL in men, below 50 mg/dL in women, or already treated for it | Falls as triglycerides rise; see the high cholesterol guide |
| Blood pressure | 130 mmHg systolic or above, or 85 mmHg diastolic or above, or already treated for it | Vascular effects of insulin resistance and sodium handling; see high blood pressure |
| Fasting glucose | 100 mg/dL or above, or already treated for it | Glucose handling that has begun to fail; see the diabetes guide |
The five criteria are the diagnosis. These are the measurements that tell you what is happening underneath it.
| Measure | What it tells you | What it misses |
|---|---|---|
| Waist circumference and waist-to-height ratio | Abdominal fat, scaled to body size in the second case | Technique varies between measurers, and both remain external proxies |
| Fasting lipid panel | Triglycerides and HDL, two of the five criteria, in one test | A single reading; triglycerides in particular move a great deal with recent eating and alcohol |
| Fasting glucose and HbA1c | Whether glucose handling has already been affected, and roughly for how long | Both can be normal while insulin resistance is well established |
| Repeated blood pressure readings | Whether the blood pressure criterion is genuinely met | Single clinic readings mislead in both directions; home readings over days are more informative |
| Liver enzymes and liver imaging | Fatty liver, which frequently travels with the same insulin resistance | Enzymes are often normal in significant steatosis; see the NAFLD guide |
| Sleep apnea screening | A common, treatable and frequently missed contributor to blood pressure and daytime fatigue | Requires asking; it is rarely raised by the patient |
| Uric acid | Often raised alongside insulin resistance, and relevant if there is joint pain | Not a criterion, and raised levels alone are not a diagnosis |
Dietary pattern, modest weight loss, activity, sleep, and treating what travels with it
Two dietary patterns carry the strongest randomised evidence here, and they overlap considerably.
Vegetables, legumes, fruit, nuts, intact whole grains, fish, and olive oil as the main fat. Modest dairy and poultry, little red and processed meat, little confectionery.
Its advantage for this cluster is breadth: it moves triglycerides, HDL, blood pressure and glycaemic markers together rather than one at a time.
Built for blood pressure and strongest there. The original trial lowered blood pressure without weight loss or sodium restriction10, and reducing sodium on top of it lowered it further still11.
Choose it if blood pressure is the criterion furthest from target. See high blood pressure.
| Change | Which criteria it tends to move | Practical note |
|---|---|---|
| Remove sugar-sweetened drinks | Triglycerides, fasting glucose, waist | The highest-yield single change. Water, unsweetened tea and coffee are the substitutions with no downside |
| Olive oil as the principal fat | HDL, triglycerides | Replacing other fats rather than adding to them is what the trials tested |
| Legumes several times a week | Fasting glucose, triglycerides | Fibre and protein together; among the cheapest changes available |
| Intact whole grains instead of refined | Fasting glucose, waist | Intact grains, not simply products labelled wholemeal |
| Oily fish twice a week | Triglycerides | Food first. See the supplement section on why the capsule is not equivalent |
| Reduce sodium | Blood pressure | Most dietary sodium comes from processed food rather than the salt cellar |
| Limit alcohol | Triglycerides, blood pressure, waist | Triglycerides in particular are sensitive to alcohol, and the effect appears quickly |
The dietary pattern does the work here. These are for correcting shortfalls and supporting it, not for replacing it.
| Supplement | What it is actually for | Typical range | Timing | Notes & cautions |
|---|---|---|---|---|
| Magnesium | Correcting a shortfall, which is common on Western dietary patterns. Higher dietary magnesium intake is associated with lower odds of metabolic syndrome in a dose-response meta-analysis13. | 200 to 400 mg per day of elemental magnesium if intake from food is low | Evening, with food | The association is observational, so this corrects a dietary shortfall rather than treating the syndrome. Citrate and glycinate are better tolerated than oxide. Reduce or avoid in reduced kidney function, where magnesium accumulates; see chronic kidney disease. Can loosen stools. |
| Viscous fibre (psyllium) | Glycaemic steadiness and satiety where fibre from food is hard to reach. | 3 to 10 g per day, divided | With water, before meals | Increase slowly to limit bloating. Take at least 2 hours apart from medication, since viscous fibre can reduce absorption. Anyone with a stricture or previous bowel obstruction should not take bulking fibre without medical advice. |
| Omega-3 (EPA and DHA) | Lowering raised triglycerides specifically, which is one of the five criteria. Not for the other four. | Food first, oily fish twice weekly. Supplement doses for raised triglycerides are set with a clinician | With a fat-containing meal | The triglyceride effect is dose-dependent and the doses used clinically are well above general-health doses, which is why this is a prescriber conversation. Tell your clinician if you take an anticoagulant or antiplatelet, and before any planned surgery. |
| Vitamin D3 | Correcting a documented deficiency, which is more common at higher body weight because vitamin D distributes into adipose tissue. | Test 25-OH-D first and set the dose with your clinician | With a fat-containing meal | Correct a deficiency because it is a deficiency. Trials of vitamin D given to improve glycaemic or cardiovascular outcomes have not shown the benefit the observational data suggested. Retest at 3 months. |
Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.
Last reviewed 2 September 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.14 This page is nutrition education, not medical advice, and it does not replace your doctor. Nutrition does not treat metabolic syndrome on its own. Blood pressure, lipids and glucose each need treating on their own terms, and a dietary pattern is not a substitute for a medicine that is doing a job. What nutrition education can do is help you understand the evidence well enough to have a better conversation with the clinician who does treat you.